PG
MYGN icon

PEAK6 Group’s Myriad Genetics MYGN Stock Holding History

PEAK6 Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$542K Sell
14,500
-18,300
-56% -$618K ﹤0.01% 2521
2018
Q1 		$969K Sell
32,800
-12,200
-27% -$413K ﹤0.01% 2000
2017
Q4 		$1.55M Sell
45,000
-23,000
-34% -$776K 0.01% 1589
2017
Q3 		$2.46M Sell
68,000
-23,400
-26% -$667K 0.01% 1218
2017
Q2 		$2.36M Buy
91,400
+12,800
+16% +$272K 0.01% 1208
2017
Q1 		$1.51M Sell
78,600
-21,600
-22% -$383K 0.01% 1348
2016
Q4 		$1.67M Buy
100,200
+72,500
+262% +$1.31M 0.01% 1460
2016
Q3 		$570K Buy
27,700
+5,000
+22% +$127K ﹤0.01% 2234
2016
Q2 		$695K Buy
22,700
+22,300
+5,575% +$775K 0.01% 2101
2016
Q1 		$15K Buy
+400
New +$15.1K ﹤0.01% 4152
2015
Q4 		– Sell
-173,200
Closed -$6.49M – 5105
2015
Q3 		$6.49M Buy
173,200
+158,900
+1,111% +$5.64M 0.03% 717
2015
Q2 		$486K Buy
14,300
+9,500
+198% +$323K ﹤0.01% 2788
2015
Q1 		$170K Sell
4,800
-39,500
-89% -$1.41M ﹤0.01% 3565
2014
Q4 		$1.51M Sell
44,300
-400
-0.9% -$14.2K 0.01% 1597
2014
Q3 		$1.72M Buy
44,700
+6,200
+16% +$231K 0.01% 1372
2014
Q2 		$1.5M Sell
38,500
-5,200
-12% -$193K 0.01% 1288
2014
Q1 		$1.49M Buy
+43,700
New +$1.35M 0.01% 1508
2013
Q3 		– Sell
-27,400
Closed -$736 – 5340
2013
Q2 		$736 Buy
+27,400
New +$794K ﹤0.01% 2416

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PEAK6 Group's MYGN Position: Q2 2018 in Review

PEAK6 Group sold out of Myriad Genetics (MYGN) in Q2 2018, closing a stake of 8,392 shares — an estimated $283K sold.

PEAK6 Group first reported a position in MYGN in Q2 2013 and held it in 5 quarters. The position peaked at $314K in Q4 2017. 258 funds tracked by Wall St. Rank hold MYGN as of Q2 2018.

  • PEAK6 Group reported no remaining Myriad Genetics position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 8,392 Myriad Genetics shares in Q2 2018, an estimated $283K.
  • PEAK6 Group first reported a position in Myriad Genetics in Q2 2013 and held it in 5 quarters.
  • PEAK6 Group's Myriad Genetics position peaked at $314K in Q4 2017.
  • 258 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.